Upfront surgery for N2 NSCLC: a large retrospective multicenter cohort study.

Alessio CampisiChiara CatelliPiotr GabryelRiccardo GiovannettiAndrea Dell'AmoreMariusz KasprzykCezary PiwkowskiMaurizio Infante

Published in: General thoracic and cardiovascular surgery (2023)

Upfront surgery followed by adjuvant therapy does not appear inferior in terms of recurrence, OS and DFS, compared to induction chemotherapy with subsequent surgery.

Keyphrases

minimally invasive
coronary artery bypass
surgical site infection
small cell lung cancer
cross sectional
percutaneous coronary intervention
coronary artery disease
tyrosine kinase